NewsBenzingaJP Morgan behält die Einstufung „Overweight“ für Las Vegas Sands bei und senkt das Kursziel auf 50 US-Dollar JP Morgan behält die Einstufung „Overweight“ für Las Vegas Sands bei und senkt das Kursziel auf 50 US-Dollar Benzinga 2026.10.22 14:13 (GMT+0) Open on Benzinga Other news Wedbush Maintains Outperform on Spyre Therapeutics, Lowers Price Target to $120 Autolus Therapeutics To Present Clinical Update Abstracts At American Society of Hematology Meeting, December 12-15 Wedbush Maintains Neutral on Ultragenyx Pharmaceutical, Lowers Price Target to $22 Magic Empire Global Secures $100M Facility From Anyu International To Finance Its Timber Supply Chain Trading Operations Wedbush Maintains Outperform on Denali Therapeutics, Raises Price Target to $24 Conference call: Stanley Black & Decker Sees FY 2026 Sales expected to be flat YoY
Autolus Therapeutics To Present Clinical Update Abstracts At American Society of Hematology Meeting, December 12-15
Magic Empire Global Secures $100M Facility From Anyu International To Finance Its Timber Supply Chain Trading Operations
